Robbins Arroyo LLP Is Investigating the Officers and Directors of Insmed, Inc. (INSM) on Behalf of Shareholders
November 04 2016 - 3:05PM
Business Wire
Shareholder rights law firm Robbins Arroyo LLP is investigating
whether certain officers and directors of Insmed, Inc. (NASDAQGS:
INSM) breached their fiduciary duties to shareholders by misleading
investors about the company's lead product candidate. Insmed, a
biopharmaceutical company, focuses on the development and
commercialization of inhaled therapies for patients with serious
lung diseases.
View this press release on the law firm's Shareholder Rights
Blog:
www.robbinsarroyo.com/shareholders-rights-blog/insmed-inc-nov-2016
Insmed Shareholders Have Legal Options
Concerned shareholders who would like more information about
their rights and potential remedies can contact attorney Darnell R.
Donahue at (800) 350-6003, DDonahue@robbinsarroyo.com, or via the
shareholder information form on the firm's website.
Robbins Arroyo LLP is a nationally recognized leader in
shareholder rights law. The firm represents individual and
institutional investors in shareholder derivative and securities
class action lawsuits, and has helped its clients realize more than
$1 billion of value for themselves and the companies in which they
have invested.
Attorney Advertising. Past results do not guarantee a similar
outcome.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161104005991/en/
Robbins Arroyo LLPDarnell R. Donahue(619) 525-3990 or Toll Free
(800) 350-6003DDonahue@robbinsarroyo.comwww.robbinsarroyo.com
Insmed (NASDAQ:INSM)
Historical Stock Chart
From Mar 2024 to Apr 2024
Insmed (NASDAQ:INSM)
Historical Stock Chart
From Apr 2023 to Apr 2024